Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes increased to $41.8 million in Q1 2026 from $34.9 million in Q1 2025, a $6.9 million or 20 per cent increase driven by deeper penetration in existing markets, the Québec vape launch, and new genetics/product additions.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Nextleaf reports fiscal year 2025 financial performance
2 | High Tide reports Q4 and 2025-year end financial results featuring record revenue
3 | Canopy Growth to report Q3 fiscal 2026 financial results on February 6, 2026
Top Cannabis Stocks Jan. 23 to Jan. 30, 2026
1. T.CURA | 6,987 views | Curaleaf Holdings Inc.
2. T.LABS| 5,832 views | Medipharm Labs Corp.
3. T.TLRY| 3,086 views | Tilray Brands Inc.
4. C.TGIF | 496 views | 1933 Industries Inc.
5. T.OGI | 416 views | Organigram Global Inc.
6. C.BLO | 272 views | Cannabix Technologies Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.